Ataxia-telangiectasia is a rare genetic condition that affects movement control, the immune system, and how the body repairs DNA. Early symptoms of ataxia-telangiectasia often start in early childhood with unsteady walking and frequent falls, and many develop small widened blood vessels on the eyes or skin. People with ataxia-telangiectasia are prone to lung infections and have a higher risk of certain cancers, and life expectancy can be reduced, though it varies. Treatment focuses on managing features with physical therapy, speech therapy, infection prevention, and careful cancer screening. Genetic counseling and coordinated care with neurology, immunology, and pulmonology teams can help many living with ataxia-telangiectasia maintain function and quality of life.
Overview
Ataxia-telangiectasiaSymptoms
Ataxia-telangiectasia causes progressive balance and coordination problems, often starting in early childhood. Early symptoms of Ataxia-telangiectasia include frequent falls, slurred speech, and trouble with eye movements. Many also have eye redness from small surface vessels, recurrent infections, and swallowing difficulties.
Outlook and prognosis
Many living with ataxia‑telangiectasia (A‑T) gradually develop coordination challenges and immune vulnerability, so everyday tasks and school or work often need adaptations over time. Respiratory infections and certain cancers are more common and drive health risks. With proactive care—vaccinations, airway support, nutrition, targeted therapies, and cancer surveillance—people with A‑T can extend function and quality of life.
Causes and risk factors
Ataxia-telangiectasia results from pathogenic variants in both copies of the ATM gene, usually inherited in an autosomal recessive pattern. Risk is higher when both parents are carriers or are closely related. Ionizing radiation exposure can worsen health problems in ataxia-telangiectasia.
Genetic influences
Genetics are central in ataxia‑telangiectasia: almost all cases result from inherited changes in the ATM gene. Variants disrupt cell DNA repair and immune function, driving neurodegeneration and cancer risk. Carrier status matters for families and reproductive planning.
Diagnosis
Doctors suspect Ataxia-telangiectasia from characteristic clinical features and lab clues. Confirmation usually uses genetic tests for ATM variations, sometimes with brain MRI or immune testing. This approach supports the genetic diagnosis of Ataxia-telangiectasia.
Treatment and drugs
Treatment for ataxia-telangiectasia focuses on easing symptoms, supporting movement and immunity, and preventing complications. Care often includes physical and speech therapy, chest physiotherapy, antibiotics or immunoglobulin therapy, nutrition support, and careful cancer screening. A specialist team coordinates care and vaccines.
Symptoms
Unsteady walking, eye redness from tiny surface vessels, and frequent chest or sinus infections can raise concern for Ataxia-telangiectasia. People may notice early features of Ataxia-telangiectasia in toddlerhood or early childhood, often as clumsiness and frequent falls. Features vary from person to person and can change over time.
Unsteady walking, wide-based steps, and frequent stumbles are common. These movement changes often appear in early childhood in Ataxia-telangiectasia. Tasks that need fine control, like using utensils, can take extra effort.
Starting a quick eye shift can be hard, so the head may jerk to help the eyes move. This can make reading lines of text slow or tiring in Ataxia-telangiectasia. Teachers may notice slower copying from the board.
Speech may sound slow or slurred. Longer conversations can be tiring, and others may ask for repeats. Background noise can make clarity worse.
Coughing or choking with thin liquids can happen. Meals may take longer, and some foods feel stuck or go down the wrong way. This can lead to chest infections if food or drink enters the airway.
How people usually first notice Ataxia-telangiectasia?
Many families first notice the first signs of ataxia-telangiectasia in early childhood when a toddler who previously walked steadily begins to stagger, wobble, or fall more often, and eye movements may look jerky. As time passes, caregivers or doctors may spot tiny widened blood vessels on the whites of the eyes (telangiectasias) and frequent chest or sinus infections that seem out of proportion to common colds. In clinics, concerns about delayed motor milestones, slurred speech, or trouble with balance often prompt testing that confirms how ataxia-telangiectasia is first noticed.
Types of Ataxia-telangiectasia
Ataxia-telangiectasia (A-T) has a few recognized clinical variants that track with how much working ATM gene activity remains. These variants can look quite different day to day—from early balance problems to later immune issues—so families often hear about “classic” versus “variant” A-T. Clinicians often describe them in these categories: classic A-T, variant A-T with residual ATM function, and ATM-related carrier effects in adults. Not everyone will experience every type.
Classic A-T
Symptoms usually begin in early childhood with unsteady walking and frequent falls. Small widened blood vessels on the eyes or skin and frequent infections are common over time. Some develop lung problems and increased cancer risk.
Variant A-T
Onset is later and movement issues progress more slowly. Immune problems and telangiectasias may be milder or even subtle. Cancer risk can still be higher than average.
ATM carriers (heterozygous)
Most carriers have no childhood symptoms of A-T. In adulthood, there may be a modestly increased risk of certain cancers, especially breast cancer. This is considered an ATM-related condition rather than A-T itself, but people often ask about types of ataxia-telangiectasia.
What genetics can tell you about symptoms
Some people with certain ATM gene changes develop early balance and coordination problems, frequent falls, and slurred speech, while others have milder movement issues that appear later. Specific variants also raise risks for eye telangiectasias, recurrent infections, and higher lifetime cancer risk.
Causes and risk factors
Ataxia-telangiectasia is caused by two harmful changes in the ATM gene that affect DNA repair, usually inherited from carrier parents.
Family history and parents who are related by blood raise the chance a child will be affected.
Genes set the stage, but environment and lifestyle often decide how the story unfolds.
People with ataxia-telangiectasia are very sensitive to medical radiation, and they also have a higher risk of some cancers.
Early symptoms of ataxia-telangiectasia may prompt genetic testing and counseling.
Environmental and biological risk factors
Risk for ataxia-telangiectasia largely comes from biology present at conception, and there are few confirmed external triggers. Doctors often group risks into internal (biological) and external (environmental). If you’re reading about early symptoms of ataxia-telangiectasia, it also helps to know what might influence risk before or during pregnancy. Below are the environmental and biological factors researchers consider, including where evidence is limited.
As men get older, new changes can appear more often in sperm. This slightly increases the chance of some rare conditions starting for the first time in a child. For ataxia-telangiectasia, this appears to be an uncommon route.
When parents are closely related by blood, they share more of the same biology. This can raise the chance that a rare condition appears in their child. Clinicians can offer tailored guidance about personal risk.
High doses of ionizing radiation to the ovaries or testicles can injure reproductive cells. This might raise the chance of rare conditions in future pregnancies. A direct link to ataxia-telangiectasia has not been confirmed.
Some treatments, like certain chemotherapies or pelvic radiation, can affect eggs or sperm. The effect depends on the specific drugs, dose, and time since treatment. If pregnancy is planned after therapy, a preconception consult can help review risks.
Genetic risk factors
If ataxia-telangiectasia (A-T) runs in a family, the genetics usually trace back to changes in the ATM gene. The condition appears when a child inherits two nonworking copies, one from each parent, though the exact variant can influence how early symptoms of ataxia-telangiectasia show up and how severe they become. Families with shared ancestry or known ATM variants may have higher chances of having another child with A-T. In some cases, genetic testing can give a clearer picture of your personal risk.
ATM gene changes: A-T happens when both copies of the ATM gene have harmful changes that disrupt the cell's DNA damage response. Many different changes can cause this, and the exact change can affect age at onset and severity.
Autosomal recessive pattern: A-T occurs when a child inherits one nonworking ATM gene from each parent. Each pregnancy between two carriers has a 25% chance for A-T and a 50% chance for a carrier child.
Single-copy carriers: Having one ATM variant does not cause A-T, but it means children could inherit it. Testing a partner can clarify the chance for A-T in future pregnancies.
Family history: Having a sibling or close relative with A-T or a known ATM variant increases the chance of being a carrier. Targeted testing for the family’s specific variant is often most informative.
Shared ancestry/consanguinity: When parents are related by blood or come from a small, isolated community, both may carry the same ATM variant. This raises the likelihood that a child will inherit A-T.
Founder variants: Some populations have ATM changes that are more common due to a shared ancestor. Knowing this can guide focused testing and counseling.
Variant effect on severity: The type of ATM change can shape the course of A-T. Changes that completely stop the gene’s function tend to cause earlier, more severe disease, while partial-function changes may lead to milder or later-onset forms.
Lifestyle risk factors
Ataxia-telangiectasia is a genetic condition; lifestyle habits do not cause it, but they can influence symptom control, complication risk, and quality of life. Focusing on how lifestyle affects Ataxia-telangiectasia can help tailor daily routines to preserve function and reduce infections. Below are practical lifestyle risk factors for Ataxia-telangiectasia that can meaningfully change outcomes.
Regular, supervised balance and strength work can help maintain mobility and reduce deconditioning in ataxia. Avoid high-fall-risk or contact activities that can lead to injuries and fractures.
Daily breathing exercises and chest physiotherapy can improve mucus clearance in weak cough and reduce respiratory infections. In A-T, fewer infections can slow decline in lung function.
Adequate calories and protein support muscle maintenance and immune resilience in A-T. Working with a dietitian on nutrient-dense meals can prevent weight loss and fatigue.
Eating slowly, taking small bites, and staying upright during and after meals lower aspiration risk in A-T. Texture-modified foods and thickened liquids can further reduce choking and pneumonia.
Risk prevention
Ataxia-telangiectasia is a genetic condition, so you can’t prevent it outright, but you can lower the chance of complications and protect long‑term health. Prevention is about lowering risk, not eliminating it completely. Daily habits, smart medical choices, and timely check‑ups can reduce infections, support breathing, and catch problems early. Knowing early symptoms of ataxia-telangiectasia can also prompt faster care when infections or cancers arise.
Keep up with inactivated vaccines like flu and pneumonia shots to reduce serious infections. Ask your care team about live vaccines, which may or may not be recommended depending on immune function.
Practice frequent handwashing and avoid close contact with people who are sick, especially during outbreaks. Have a sick‑day plan for prompt testing and treatment, since infections can be more severe in ataxia-telangiectasia.
Minimize X‑rays and CT scans when safe alternatives like ultrasound or MRI are available. Tell every clinic and hospital about ataxia-telangiectasia, because people with it are highly sensitive to ionizing radiation.
Schedule regular check‑ups to review blood counts and lymph nodes, and report persistent fevers, night sweats, easy bruising, or swollen glands. People with ataxia-telangiectasia have higher risks for certain cancers, so early evaluation matters.
Transmission
Ataxia-telangiectasia is a genetic condition; it cannot be caught or passed between people through contact, coughing, or bodily fluids. The genetic transmission of ataxia-telangiectasia follows an autosomal recessive pattern caused by a change in a single gene. Most children with ataxia-telangiectasia inherit one nonworking copy of the gene from each parent, who are usually healthy carriers. When both parents are carriers, each pregnancy has a 25% (1 in 4) chance of a child with the condition, a 50% (1 in 2) chance of a carrier, and a 25% chance of neither. Less often, a new (de novo) change arises in the gene, but ataxia-telangiectasia still does not spread between people.
When to test your genes
Test your genes if you or a close relative developed unexplained ataxia (unsteady movement), recurrent infections, or telangiectasias in childhood, or if a sibling has confirmed Ataxia‑telangiectasia. Adults with early cancers, unusual radiation sensitivity, or a family history of A‑T should also consider testing. Genetic results can guide surveillance, infection prevention, and safer cancer care.
Diagnosis
Trouble with balance, frequent falls, and eye redness in early childhood often prompt the first medical visits. Many people feel relief just knowing what’s really going on. Doctors look at patterns over time and then use targeted tests to confirm the genetic diagnosis of Ataxia-telangiectasia. Getting the right answer helps guide care, infection prevention, and long-term planning.
Providers look for early-onset balance problems, slurred speech, and small dilated blood vessels on the eyes or skin. These patterns together raise suspicion for Ataxia-telangiectasia.
Doctors assess coordination, gait, reflexes, and eye movements. Progressive coordination loss with normal muscle strength can point toward Ataxia-telangiectasia.
An eye doctor checks for telangiectasias on the whites of the eyes. Finding these along with balance issues supports the diagnosis.
Alpha-fetoprotein (AFP) levels are often elevated after early childhood. Low lymphocyte counts or low IgA/IgG subclasses can suggest immune involvement seen in Ataxia-telangiectasia.
Stages of Ataxia-telangiectasia
Ataxia-telangiectasia does not have defined progression stages. It tends to change in a mixed way over time, with movement challenges, immune problems, lung issues, and cancer risk appearing at different ages and progressing at different speeds for each person. Different tests may be suggested to help confirm the diagnosis and check how the immune system and nerves are working. Doctors look at early symptoms of Ataxia-telangiectasia—such as unsteady walking in early childhood and tiny widened blood vessels on the whites of the eyes—along with blood tests and genetic testing, and then monitor progress with regular checkups.
Outlook and prognosis
Daily life with ataxia-telangiectasia (A‑T) often involves planning around balance issues, frequent infections, and fatigue—like leaving extra time for walking, using mobility aids at school or work, and keeping up with therapies. Even though it can feel overwhelming, many people with A‑T build routines that make space for treatments, school or jobs, and social time. Early care can make a real difference in how symptoms progress and how independent someone can stay. Doctors call this the prognosis—a medical word for likely outcomes.
The outlook is not the same for everyone, but A‑T is usually progressive, with coordination and speech changes becoming more noticeable over childhood and adolescence, and immune problems raising the risk of lung infections. Some people experience slower changes and fewer infections, while others notice quicker loss of balance or more frequent illness. Cancer risk is higher than average, especially for certain blood cancers, so regular screening and prompt evaluation of new symptoms are important. In many clinics, careful infection prevention, chest physiotherapy, feeding support when needed, and tailored physical therapy help preserve strength and reduce complications; early symptoms of ataxia-telangiectasia like frequent stumbling or slurred speech are often when these supports begin.
Looking at the long-term picture can be helpful. Historically, average life expectancy was in the teens to early 20s, mainly due to lung disease and cancer; with today’s coordinated care, many now live into their late 20s or 30s, and some beyond. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Genetic testing can sometimes provide more insight into prognosis, and not everyone with the same gene change will have the same outlook. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Day to day, many people with ataxia-telangiectasia (A‑T) notice movement becoming harder, infections taking longer to shake, and clinic visits becoming a regular part of life. Early symptoms of ataxia-telangiectasia often start in early childhood, but the long‑term picture centers on how movement, immunity, lungs, and cancer risk change over time. Long-term effects vary widely, and the pace can differ even within the same family. With modern supportive care, many now live into adulthood, though health needs usually become more complex with age.
Balance and coordination tend to decline over years, leading to more falls and fatigue. Many eventually use a wheelchair for safety and energy conservation.
Speech can become slower or less clear, and swallowing may be difficult. This raises the risk of choking or food and liquid going into the lungs.
Starting quick eye movements can be hard, making reading and tracking objects tiring. Eye redness from small surface blood vessels is common but usually harmless.
Ongoing sinus, ear, and chest infections can continue and become harder to clear. Over time, repeated infections may lead to chronic lung changes.
How is it to live with Ataxia-telangiectasia?
Living with ataxia-telangiectasia often means planning your day around fatigue, balance challenges, and frequent medical visits, while still carving out space for school, work, and friendships. Many find that mobility aids, accessible environments, and clear routines make everyday tasks safer and less tiring, and that speech therapy and assistive communication help keep conversations smooth and social life intact. Families, classmates, and coworkers may take on supportive roles—helping with transportation, infection precautions, or adapting activities—yet most discover a workable rhythm that protects health without sidelining joy or independence. Over time, staying up to date on immunizations, minimizing infection risks, and coordinating care with specialists become part of life, but so do advocacy, community, and celebrating milestones on a timeline that fits you.
Treatment and drugs
Treatment for ataxia-telangiectasia (A‑T) focuses on easing symptoms, preventing complications, and supporting day-to-day function, since there’s currently no cure. Care is usually team-based, with neurologists, immunologists, pulmonologists, physical and occupational therapists, speech therapists, nutrition specialists, and sometimes oncologists working together. Supportive care can make a real difference in how you feel day to day: this can include regular physiotherapy to maintain balance and strength, speech and swallow therapy, nutrition support, and vaccines plus infection-prevention plans tailored to immune needs. Doctors may use antibiotics for infections, immune globulin therapy for antibody shortages, inhaled airway treatments and chest physiotherapy for lung health, and careful use of medicines to ease movement problems such as tremor or stiffness; cancer is treated using adjusted protocols to reduce sensitivity to radiation and certain chemotherapies. Because needs change over time, your doctor can help weigh the pros and cons of each option and update the plan as A‑T evolves.
Non-drug treatment
Ataxia-telangiectasia affects movement, immunity, and swallowing, so daily life often involves extra planning and support. Goals of care focus on staying mobile, communicating clearly, and preventing infections while keeping nutrition on track. Alongside medicines, non-drug therapies can help maintain function and comfort. Plans are tailored by age and symptoms, since early symptoms of ataxia-telangiectasia may differ from later challenges.
Targeted exercises help with balance, strength, and coordination. Therapists also work on posture and stretching to ease stiffness. This supports safer walking in ataxia-telangiectasia.
Everyday tasks are broken into simpler steps and adapted. Tools like weighted utensils or button hooks can make dressing and meals easier. Energy-saving strategies help reduce fatigue.
Speech therapy improves clarity and breath control for talking. Swallow therapy teaches safer ways to eat and drink, sometimes with thicker liquids. This can lower choking risk in ataxia-telangiectasia.
Dietitians tailor meals to maintain weight and muscle. High-calorie, high-protein options and texture changes can make eating safer and easier. Feeding tubes may be considered if swallowing becomes too hard.
Your genes may have an impact on how drugs work for you
Medicines for ataxia-telangiectasia can work differently depending on inherited gene changes that affect how the body processes drugs or how sensitive cells are to them. This is why clinicians may adjust doses carefully and avoid certain therapies, especially radiation-sensitizing treatments.
Pharmacological treatments
Medications for ataxia-telangiectasia focus on easing day-to-day symptoms, preventing infections, and supporting lung health. Care is tailored to each person’s immune and neurologic needs. Not everyone responds to the same medication in the same way. Treatment choices usually evolve over time with your care team.
IVIG or SCIG can replace missing antibodies and cut down on repeated chest, ear, or sinus infections. Infusions are given regularly and doses are adjusted based on infection history and blood levels.
Drugs like amoxicillin–clavulanate or azithromycin treat bacterial infections promptly and may be used preventively if infections keep returning. For some, frequent chest infections were among the early symptoms of Ataxia-telangiectasia, and timely antibiotics help protect lung function.
These medicines may modestly improve ataxia, tremor, or balance in some people. Benefits vary, and side effects like sleep changes or dizziness are monitored.
Baclofen or tizanidine can ease muscle stiffness and cramps that make walking or self-care harder. Doses are increased slowly to improve comfort while limiting sleepiness or low blood pressure.
Genetic influences
Genetics plays a central role in ataxia-telangiectasia (A‑T). The condition happens when both copies of a gene called ATM do not work properly. This gene helps cells sense and repair DNA damage; when it is impaired, cells in the brain, nerves, and immune system are especially affected. Ataxia-telangiectasia is inherited in an autosomal recessive pattern: when two parents each carry one nonworking ATM copy, each child has a 25% chance of having A‑T, a 50% chance of being a carrier, and a 25% chance of inheriting no change. Even with the same gene change, people can have different symptom severity or age at diagnosis. People who carry a single ATM change usually do not develop ataxia-telangiectasia but may have a modestly higher risk of certain cancers (for example, breast cancer), so adults in these families may be offered personalized screening. Testing the ATM gene can confirm the genetic causes of ataxia-telangiectasia and help identify relatives who are carriers, which can guide family planning and care.
Is Ataxia-telangiectasia genetic?
Genetics are central in ataxia‑telangiectasia: almost all cases result from inherited changes in the ATM gene. Variants disrupt cell DNA repair and immune function, driving neurodegeneration and cancer risk. Carrier status matters for families and reproductive planning.
Pharmacogenetics—how genetics influence drug effects
Changes in the ATM gene can strongly shape how people with ataxia-telangiectasia respond to treatment. Because ATM helps cells repair breaks in DNA, radiation therapy and chemotherapy drugs that damage DNA—especially those that break DNA strands—can cause unusually strong side effects, so care teams often avoid radiation and use lower doses, alternative regimens, and close monitoring. This marked radiation sensitivity in ataxia-telangiectasia means cancer care is planned carefully, favoring approaches that rely less on DNA‑damaging effects when possible. Alongside medical history and current medicines, genetic testing can help tailor choices for supportive drugs or other treatments in some cases. Other common drug–gene interactions, such as those guiding safe dosing of thiopurines or certain pain medicines, may still apply, and plans are individualized beyond genetics based on infection risk, organ function, and goals of care.
Interactions with other conditions
In people with ataxia-telangiectasia (A‑T), frequent respiratory infections and chronic lung disease often occur together, and each can make the other worse. When a cold, flu, or pneumonia hits, many notice that balance, swallowing, and fatigue temporarily worsen, and recovery can take longer. There’s also a higher lifetime risk of blood cancers and some solid tumors; because A‑T makes cells unusually sensitive to radiation, standard radiation therapy and certain chemotherapy drugs may need adjustment. Doctors call it a “comorbidity” when two conditions occur together. Autoimmune problems, liver inflammation, and insulin resistance or diabetes can develop alongside A‑T and may complicate everyday management, including nutrition and medication choices. Infections can even overshadow early symptoms of ataxia-telangiectasia, so care is often coordinated across pulmonology, immunology, neurology, and oncology to align treatments and reduce risks.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who were steady at first but then stumbled more, caught frequent chest colds, and developed tiny red “spider vein” spots on the eyes. Families and teachers often noticed the change first—falling more on the playground, a tremor when reaching for a cup, or reading trouble because the eyes wouldn’t fix smoothly. These everyday signs form the earliest thread of what we now call ataxia-telangiectasia.
First described in the medical literature as a pattern of progressive unsteadiness with eye and skin vessel changes, early reports focused on how the condition looked and felt rather than why it happened. Doctors grouped it with other movement disorders partly because the balance problems stood out and the small blood vessel “telangiectasias” were easier to see than the hidden immune problems. Over time, descriptions became more complete, noting frequent sinus and lung infections and unusual sensitivity to medical X‑rays.
In recent decades, awareness has grown as clinicians connected the movement changes, the visible vessel markings, and the immune findings into one condition. Care teams also noticed that people with ataxia-telangiectasia had a higher chance of certain cancers, which pushed researchers to look beyond the nervous system. This broadened view helped families get a single explanation instead of a patchwork of labels.
Advances in genetics provided the turning point. Researchers identified changes in a gene now known to help cells sense and repair DNA damage. That discovery explained why nerves that coordinate movement gradually falter, why tiny surface blood vessels become prominent, why infections are common, and why radiation exposure is riskier than usual. It also clarified why symptoms vary—like a dimmer switch set at different levels—because not all gene changes affect the protein in the same way.
Historical differences highlight why timing matters. Some children show early symptoms of ataxia-telangiectasia in preschool years; others walk well into school age before balance problems become clear. In the past, this variability led to missed or late diagnoses. Today, the combination of clinical features and genetic testing allows earlier recognition, more tailored infection prevention, and safer choices during imaging or cancer treatment.
From early case notes to modern labs, each step has added to the picture we have today. What began as separate observations—wobbly walking here, eye vessel spots there—has become a well-defined condition with coordinated care. This history continues to shape everyday decisions, from vaccines and physical therapy to how and when to use medical imaging, aiming to protect health while supporting mobility and independence for people living with ataxia-telangiectasia.